Product Code: ETC13139701 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Monkeypox Vaccine and Treatment Market was valued at USD 0.6 Billion in 2024 and is expected to reach USD 1.2 Billion by 2031, growing at a compound annual growth rate of 9.00% during the forecast period (2025-2031).
The Global Monkeypox Vaccine and Treatment Market is experiencing growth due to increasing awareness about the disease and the need for preventive measures. The market is driven by the rising incidence of monkeypox outbreaks and the development of vaccines and treatments. Key market players are investing in research and development activities to introduce effective vaccines and treatments to combat the disease. Additionally, government initiatives to control the spread of monkeypox are contributing to market growth. The market is characterized by collaborations between pharmaceutical companies, research institutions, and government organizations to accelerate the development and distribution of monkeypox vaccines and treatments. Overall, the Global Monkeypox Vaccine and Treatment Market is poised for significant expansion in the coming years.
The Global Monkeypox Vaccine and Treatment Market is witnessing a surge in research and development activities aimed at developing effective vaccines and treatments for this rare viral disease. With the increasing prevalence of monkeypox outbreaks in Africa and recent cases reported in other parts of the world, there is a growing demand for preventive measures and therapeutic options. Key trends include advancements in vaccine technology, such as the development of live attenuated vaccines and DNA-based vaccines, as well as the exploration of antiviral drugs for treatment. Opportunities in the market lie in collaborations between pharmaceutical companies, government agencies, and research institutions to accelerate the development and commercialization of monkeypox vaccines and treatments, as well as in expanding market reach to regions with high incidences of the disease.
The Global Monkeypox Vaccine and Treatment Market faces several challenges, including limited awareness about the disease, especially outside of Africa where it is more prevalent. This leads to a lack of investment in research and development for effective vaccines and treatments. Additionally, the similarity of symptoms between monkeypox and other diseases like chickenpox and smallpox can result in misdiagnosis and delayed treatment. The high cost of developing vaccines and treatments for a relatively rare disease like monkeypox also poses a challenge, making it less attractive for pharmaceutical companies to invest in this area. Furthermore, regulatory hurdles and the need for clinical trials to ensure safety and efficacy further slow down the development and availability of monkeypox vaccines and treatments in the market.
The Global Monkeypox Vaccine and Treatment Market is primarily driven by the increasing prevalence of monkeypox infections globally, particularly in regions where the virus is endemic. The rising awareness about the importance of preventive measures and vaccination to control the spread of the disease is also a significant driver. Additionally, government initiatives and funding for research and development of monkeypox vaccines and treatments play a crucial role in shaping the market landscape. Furthermore, advancements in healthcare infrastructure, growing investments in healthcare R&D, and collaborative efforts between pharmaceutical companies and research institutions are driving innovation in the development of effective monkeypox vaccines and treatments, further fueling market growth.
The government policies related to the Global Monkeypox Vaccine and Treatment Market primarily focus on ensuring the safety, efficacy, and accessibility of monkeypox vaccines and treatments. Regulatory bodies like the FDA and WHO oversee the approval process for monkeypox vaccines, ensuring they meet stringent standards for quality and effectiveness. Governments also prioritize funding for research and development of monkeypox vaccines and treatments to address public health concerns. Additionally, governments may implement vaccination campaigns and stockpile vaccines to prepare for potential monkeypox outbreaks. Collaboration between governments, pharmaceutical companies, and healthcare organizations is essential to address the challenges in the Global Monkeypox Vaccine and Treatment Market and ensure widespread availability of preventive measures and treatments.
The Global Monkeypox Vaccine and Treatment Market is expected to witness significant growth in the coming years due to the increasing prevalence of monkeypox outbreaks and the rising awareness about the importance of vaccination. With ongoing research and development efforts focusing on the development of effective vaccines and treatments for monkeypox, the market is poised for expansion. Factors such as government initiatives to control infectious diseases, advancements in healthcare infrastructure, and a growing emphasis on preventive healthcare are also likely to drive market growth. Additionally, collaborations between pharmaceutical companies and research institutions to accelerate the development of monkeypox vaccines and treatments are expected to further propel market growth in the future.
In the global Monkeypox Vaccine and Treatment Market, Asia is anticipated to witness significant growth due to the rising prevalence of monkeypox in countries like Nigeria and the Democratic Republic of Congo. North America is expected to hold a notable market share owing to the increasing government focus on vaccination programs and advanced healthcare infrastructure. Europe is projected to show steady growth due to the presence of key market players and growing investments in research and development activities. The Middle East and Africa region is likely to witness moderate growth due to improving healthcare facilities and increasing awareness about preventive measures. Latin America is also expected to experience growth driven by government initiatives to control infectious diseases and the rising demand for effective monkeypox vaccines and treatments in the region.
Global Monkeypox Vaccine and Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Monkeypox Vaccine and Treatment Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Global Monkeypox Vaccine and Treatment Market - Industry Life Cycle |
3.4 Global Monkeypox Vaccine and Treatment Market - Porter's Five Forces |
3.5 Global Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Monkeypox Vaccine and Treatment Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Global Monkeypox Vaccine and Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Monkeypox Vaccine and Treatment Market Trends |
6 Global Monkeypox Vaccine and Treatment Market, 2021 - 2031 |
6.1 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Vaccine, 2021 - 2031 |
6.1.3 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.1.4 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Vaccinia Immune Globulin (VIG), 2021 - 2031 |
6.2 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.3 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By End use, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Global Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Monkeypox Vaccine and Treatment Market, Overview & Analysis |
7.1 North America Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 - 2031 |
7.2 North America Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Monkeypox Vaccine and Treatment Market, Revenues & Volume, By End use, 2021 - 2031 |
8 Latin America (LATAM) Monkeypox Vaccine and Treatment Market, Overview & Analysis |
8.1 Latin America (LATAM) Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Monkeypox Vaccine and Treatment Market, Revenues & Volume, By End use, 2021 - 2031 |
9 Asia Monkeypox Vaccine and Treatment Market, Overview & Analysis |
9.1 Asia Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Monkeypox Vaccine and Treatment Market, Revenues & Volume, By End use, 2021 - 2031 |
10 Africa Monkeypox Vaccine and Treatment Market, Overview & Analysis |
10.1 Africa Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Monkeypox Vaccine and Treatment Market, Revenues & Volume, By End use, 2021 - 2031 |
11 Europe Monkeypox Vaccine and Treatment Market, Overview & Analysis |
11.1 Europe Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Monkeypox Vaccine and Treatment Market, Revenues & Volume, By End use, 2021 - 2031 |
12 Middle East Monkeypox Vaccine and Treatment Market, Overview & Analysis |
12.1 Middle East Monkeypox Vaccine and Treatment Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Monkeypox Vaccine and Treatment Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Monkeypox Vaccine and Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Monkeypox Vaccine and Treatment Market, Revenues & Volume, By End use, 2021 - 2031 |
13 Global Monkeypox Vaccine and Treatment Market Key Performance Indicators |
14 Global Monkeypox Vaccine and Treatment Market - Export/Import By Countries Assessment |
15 Global Monkeypox Vaccine and Treatment Market - Opportunity Assessment |
15.1 Global Monkeypox Vaccine and Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Monkeypox Vaccine and Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Monkeypox Vaccine and Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Monkeypox Vaccine and Treatment Market Opportunity Assessment, By End use, 2021 & 2031F |
16 Global Monkeypox Vaccine and Treatment Market - Competitive Landscape |
16.1 Global Monkeypox Vaccine and Treatment Market Revenue Share, By Companies, 2024 |
16.2 Global Monkeypox Vaccine and Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |